Designing and in Silico Analysis of PorB Protein from Chlamydia Trachomatis for Developing a Vaccine Candidate

 

 Buy Article Permissions and Reprints

Abstract

Bakground: Chlamydia trachomatis is an obligate, intracellular, gram-negative bacterium that causes sexually transmitted infections. The outer membrane protein PorB is a conserved chlamydial protein that functions as a porin and is a target for neutralizing antibodies (Abs); thus, making it important for vaccine development.

Methods: We used an in silico strategy and homology modeling algorithms and focused on PorB of C. trachomatis and explained its characterization with the help of bioinformatic tools to introduce it as a candidate for novel drug and vaccine design. In this study, physicochemical characterization, secondary and 3D structure, and functional site prediction were investigated. Then, a B cell epitope was analyzed using Immune Epitope Database, which predicts the target region and helps in vaccine development.

Results: PorB is a surface-exposed protein comprising 340 amino acids and frequently appears (61.76%) as a random coiled structure. PorB was present outside the cell and the maximum length of the predicted epitope was from amino acids 91–108, i. e., 18 amino acids long. This epitope can be considered for designing Abs and vaccines against C. trachomatis.

Conclusion: Although many attempts have been made to develop a vaccine against C. trachomatis, no protective vaccines are available to date. More detailed studies focusing on PorB should be performed to design vaccines against C. trachomatis because of the presence of different immunization protocols and requirement of different protective mechanisms.

• References

• 1 Fathollahzadeh B, Bahador A, Majnooni A et al. Screening of Chlamydia trachomatis infection in men. Is it necessary in Iran? Jundishapur J Microbiol 2013; 6: e7782
  PubMedGoogle Scholar
• 2 Rosenberger JG, Dodge B, Van Der Pol B et al. Reactions to self-sampling for ano-rectal sexually transmitted infections among men who have sex with men: a qualitative study. Archives of Sexual Behavior 2011; 40: 281-288
  CrossrefPubMedGoogle Scholar
• 3 Quint KD, Bom RJ, Bruisten SM et al. Comparison of 3 genotyping methods to identify Chlamydia trachomatis genotypes in positive men and women. Mol Cell Probes 2010; 24: 266-270
  CrossrefPubMedGoogle Scholar
• 4 Hakimi H, Zainodini N, Khorramdelazad H et al. Seminal Levels of Pro-inflammatory (CXCL1, CXCL9, CXCL10) and Homeostatic (CXCL12) Chemokines in Men With Asymptomatic Chlamydia trachomatis Infection. Jundishapur J Microbiol 2014; 7: e11152
  PubMedGoogle Scholar
• 5 Liu X, Afrane M, Clemmer DE et al. Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics. J Bacteriol 2010; 192: 2852-2860
  CrossrefPubMedGoogle Scholar
• 6 Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis . Infect Immun 1981; 31: 1161-1176
  PubMedGoogle Scholar
• 7 Hatch TP, Allan I, Pearce JH. Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp. J Bacteriol 1984; 157: 13-20
  PubMedGoogle Scholar
• 8 Kubo A, Stephens RS. Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target. Mol Microbio 2000; 38: 772-780
  CrossrefPubMedGoogle Scholar
• 9 Mygind PH, Christiansen G, Roepstorff P et al. Membrane proteins PmpG and PmpH are major constituents of Chlamydia L2 outer membrane complex. FEMS Microbiol Lett 2000; 186: 163-169
  CrossrefPubMedGoogle Scholar
• 10 Shaw AC, Gevaert K, Demol H et al. Comparative proteome analysis of Chlamydia trachomatis serovar A, D and L2. Proteomics 2000; 2: 164-186
  PubMedGoogle Scholar
• 11 Tanzer RJ, Hatch TP. Characterization of outer membrane proteins in Chlamydia trachomatis LGV serovar L2. J Bacteriol 2001; 183: 2686-2690
  CrossrefPubMedGoogle Scholar
• 12 Birkelund S, Morgan-Fisher M, Timmerman E et al. Analysis of proteins in Chlamydia trachomatis L2 outer membrane complex, COMC. FEMS Immunol Med Microbiol 2009; 55: 187-195
  CrossrefPubMedGoogle Scholar
• 13 Malik A, Jain S, Hakim S et al. Chlamydia trachomatis infection & female infertility. Indian J Med Res 2006; 123: 770-775
  PubMedGoogle Scholar
• 14 Baehr W, Zhang YX, Joseph T et al. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci USA 1988; 85: 4000-4004
  CrossrefPubMedGoogle Scholar
• 15 Campos M, Pal S, O'Brien TP et al. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate. Invest Ophthalmol Visual Sci 1995; 36: 1477-1491
  PubMedGoogle Scholar
• 16 Stephens RS, Sanchez-Pescador R, Wagar EA et al. Diversity of Chlamydia trachomatis major outer membrane protein genes. J Bacteriol 1987; 169: 3879-3885
  PubMedGoogle Scholar
• 17 Stephens RS, Wagar EA, Schoolnik GK. High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J Exp Med 1988; 167: 817-831
  CrossrefPubMedGoogle Scholar
• 18 Peeling R, Maclean IW, Brunham RC. In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein. Infect Immun 1984; 46: 484-488
  PubMedGoogle Scholar
• 19 Pourhajibagher M, Bahador A. In Silico Investigation for Evaluation of the Potential of the SclA Protein in Streptococcus pyogenes. Jundishapur J Microbiol 2015; 8: e19296
  PubMedGoogle Scholar
• 20 Van Drunen Littel-van den Hurk S, Gerdts V, Loehr BI et al. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Advanced Drug Delivery Reviews 2000; 43: 13-28
  CrossrefPubMedGoogle Scholar
• 21 Olive C, Toth I, Jackson D. Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies. Mini Rev Med Chem 2001; 1: 429-438
  CrossrefPubMedGoogle Scholar
• 22 Wilkowska-Trojniel M, Zdrodowska-Stefanow B, Ostaszewska-Puchalska I et al. Chlamydia trachomatis urogenital infection in women with infertility. Adv Med Sci 2009; 54: 82-85
  PubMedGoogle Scholar
• 23 Verweij SP, Lanjouw E, Bax CJ et al. Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections. BMC Infectious Diseases 2014; 14: 1-7
  CrossrefPubMedGoogle Scholar
• 24 Boekhorst J, Been MW, Kleerebezem M et al. Genome-wide detection and analysis of cell wall-bound proteins with LPxTG-like sorting motifs. J Bacteriol 2005; 187: 4928-4934
  CrossrefPubMedGoogle Scholar
• 25 McMillan DJ, Geffers R, Buer J et al. Variations in the distribution of genes encoding virulence and extracellular proteins in group A streptococcus are largely restricted to 11 genomic loci. Microbes Infect 2007; 9: 259-270
  CrossrefPubMedGoogle Scholar
• 26 Longbottom D. Chlamydial vaccine development. Journal of Medical Microbiology 2003; 52: 537-540
  CrossrefPubMedGoogle Scholar